Source: Neurotoxicity Research. Unidades: FORP, FMRP
Subjects: DOENÇAS NEURODEGENERATIVAS, CITOCINAS, DOENÇA DE PARKINSON, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTA-CECÍLIA, Flávia V. et al. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotoxicity Research, v. 29, n. 4, p. 447-459, 2016Tradução . . Disponível em: https://doi.org/10.1007/s12640-015-9592-2. Acesso em: 07 jun. 2024.APA
Santa-Cecília, F. V., Socias, B., Ouidja, M. O., Sepulveda-Diaz, J. E., Acuña, L., Silva, R. L., et al. (2016). Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotoxicity Research, 29( 4), 447-459. doi:10.1007/s12640-015-9592-2NLM
Santa-Cecília FV, Socias B, Ouidja MO, Sepulveda-Diaz JE, Acuña L, Silva RL, Michel PP, Del Bel EA, Cunha TM, Raisman-Vozari R. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways [Internet]. Neurotoxicity Research. 2016 ; 29( 4): 447-459.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1007/s12640-015-9592-2Vancouver
Santa-Cecília FV, Socias B, Ouidja MO, Sepulveda-Diaz JE, Acuña L, Silva RL, Michel PP, Del Bel EA, Cunha TM, Raisman-Vozari R. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways [Internet]. Neurotoxicity Research. 2016 ; 29( 4): 447-459.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1007/s12640-015-9592-2
